{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T05:20:16Z","timestamp":1697347216998},"reference-count":23,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2005,6,7]],"date-time":"2005-06-07T00:00:00Z","timestamp":1118102400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Functional gastrointestinal (GI) disorders are common in primary care. However, proper pharmacological approaches have not yet been established. The reason for a lack of proper approaches may be attributable to the lack in clarity of their pathogenesis and pathophysiology. Meta\u2010analysis of pharmacological approaches to functional GI disorders failed to identify the solid cluster of patients\u2019 symptoms.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002The aim of this study is to assess the perspective of primary care doctors concerning prescriptions for functional GI symptoms, evaluate the efficacy of the drugs prescribed, and the need for medication for these symptoms.<\/jats:p><jats:p><jats:bold>Method<\/jats:bold> :\u2002Questionnaires were sent to primary care doctors, and a total of 149 responses were obtained. Efficacy of each medication was evaluated by the number of doctors favouring the category, and the respective impressions of prescriptions given.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Symptoms of heartburn were well controlled by anti\u2010secretory drugs (H2RAs and PPIs), while appetite loss and abdominal gurgling were not controlled by any medications.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002This survey reveals differences in need for various prescription drugs in functional GI symptoms.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02474.x","type":"journal-article","created":{"date-parts":[[2005,6,19]],"date-time":"2005-06-19T15:51:18Z","timestamp":1119196278000},"page":"47-54","source":"Crossref","is-referenced-by-count":4,"title":["Primary care in the treatment of functional gastrointestinal symptoms in Japan: prescription preferences and impression of results"],"prefix":"10.1111","volume":"21","author":[{"given":"M.","family":"Hongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kanatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Karahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.suppl_4.iv72"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(00)02314-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655202761020533"},{"key":"e_1_2_6_5_2","first-page":"281","article-title":"Criteria used by general practitioners in prescribing prokinetic or antisecretory drugs in patients with functional dyspepsia","volume":"93","author":"Mones J","year":"2001","journal-title":"Rev Esp Enferm Dig"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025264"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40122.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655299750025255"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609095545"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii78"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii69"},{"key":"e_1_2_6_12_2","first-page":"660","article-title":"Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials","volume":"91","author":"Veldhuyzen van Zanten SJ","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00086-8"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430200044008"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"key":"e_1_2_6_17_2","article-title":"Pharmacological interventions for non\u2010ulcer dyspepsia","author":"Moayyedi P","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.suppl_4.iv36"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01044.x"},{"key":"e_1_2_6_20_2","first-page":"619","article-title":"A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome","volume":"51","author":"Lewin van den Broek NT","year":"2001","journal-title":"Br J Gen Pract"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.030"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90142-Y"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(98)70002-5"},{"key":"e_1_2_6_24_2","first-page":"2024","article-title":"Pharmacological treatment of dyspeptic symptoms","volume":"19","author":"Hongo M","year":"1999","journal-title":"Progr Med"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02474.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02474.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T19:43:58Z","timestamp":1695757438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02474.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":23,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02474.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02474.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}